RepliCel Life Sciences, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Public
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.replicel.com
Long-Term Follow-up of the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis
Withdrawn
- Conditions
- TendinosisTendinopathy
- First Posted Date
- 2016-01-13
- Last Posted Date
- 2016-04-07
- Lead Sponsor
- RepliCel Life Sciences, Inc.
- Registration Number
- NCT02655042
- Locations
- 🇨🇦
Alan McGavin Sports Medicine Centre, Vancouver, British Columbia, Canada
Study of Intradermal Injections of RCS-01 in Male and Female Subjects
Phase 1
Completed
- Conditions
- Intrinsic Aging of SkinSkin WrinklingSolar Degeneration of Skin
- Interventions
- First Posted Date
- 2015-03-18
- Last Posted Date
- 2017-10-11
- Lead Sponsor
- RepliCel Life Sciences, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT02391935
- Locations
- 🇩🇪
IUF Leibniz-Institut für umweltmedizinische Forschung gGmbH, Düsseldorf, Germany
Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis
- First Posted Date
- 2015-01-01
- Last Posted Date
- 2017-09-28
- Lead Sponsor
- RepliCel Life Sciences, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT02330146
- Locations
- 🇨🇦
Allan McGavin Sports Medicine Centre, Vancouver, British Columbia, Canada
© Copyright 2025. All Rights Reserved by MedPath